A rare but troubling side effect
New concerns about blood clots associated with drug-coated stents could hurt Boston Scientific's bottom line as doctors grow more wary about them
The product is one of the biggest-selling medical devices in history. The side effect is rare and deadly. And the impact is a giant question mark hanging over Boston Scientific Corp. , the region's biggest life-science company. (Full article: 1273 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
